A Potential Breakthrough in Multiple Sclerosis Treatments – BioNTech Trials MS Vaccine
Over two million people worldwide are affected by multiple sclerosis, or MS for short. This includes over 400,000 individuals in
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.